Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
03-05

DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 5.98% to $1.95 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.35% to 18,285.16 and Dow Jones Industrial Average falling 1.55% to 42,520.99.

Inovio Pharmaceuticals Inc. closed 86.78% short of its 52-week high of $14.75, which the company achieved on April 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.11% to $165.42, Statera Biopharma Inc. (STAB) rose 200.00% to $0.00, and Pfizer Inc. $(PFE)$ fell 1.90% to $25.75.

Trading volume (638,667) remained 337,017 below its 50-day average volume of 975,684.

Data source: Dow Jones Market Data, FactSet. Data compiled March 4, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 04, 2025 17:26 ET (22:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10